Literature DB >> 1437278

Immunization against cerebral pathology in Plasmodium berghei-infected mice.

J H Curfs1, C C Hermsen, J H Meuwissen, W M Eling.   

Abstract

The development of cerebral lesions in Plasmodium berghei-infected mice was dependent on the strain of mice and the size of the infectious inoculum. In particular, C57Bl/6J mice develop cerebral lesions when infected with low numbers of parasitized erythrocytes. By increasing the number of parasites in the infectious inoculum, the percentage of animals that develop cerebral malaria is decreased. Varying degrees of protection against the development of cerebral malaria can be obtained by several methods of immunization. (1) Injection of mice with large numbers of disrupted parasitized erythrocytes 1 or 2 weeks before the challenge infection (protection up to 70%). (2) A 2-day immunizing infection given 9 or 14 days before the challenge infection (protection up to 85%). (3) Injection of mice with plasmodial exoantigen preparations 1 week before the challenge infection (variable protection-rate, up to 100%). In all mice protected against cerebral malaria, parasitaemia is not affected by the immunizing treatment, indicating that protective mechanisms against cerebral malaria and parasitaemia are independent.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1437278     DOI: 10.1017/s0031182000073625

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  10 in total

1.  Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice.

Authors:  N S Postma; R C Hermsen; D J Crommelin; W M Eling; J Zuidema
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Early cytokine production is associated with protection from murine cerebral malaria.

Authors:  Andrew J Mitchell; Anna M Hansen; Leia Hee; Helen J Ball; Sarah M Potter; John C Walker; Nicholas H Hunt
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria.

Authors:  V Amani; M I Boubou; S Pied; M Marussig; D Walliker; D Mazier; L Rénia
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

4.  Evidence for multiple pathologic and protective mechanisms of murine cerebral malaria.

Authors:  V M Jennings; A A Lal; R L Hunter
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

5.  Suppression of CD4+ Effector Responses by Naturally Occurring CD4+ CD25+ Foxp3+ Regulatory T Cells Contributes to Experimental Cerebral Malaria.

Authors:  Anne-Laurence Blanc; Tarun Keswani; Olivier Gorgette; Antonio Bandeira; Bernard Malissen; Pierre-André Cazenave; Sylviane Pied
Journal:  Infect Immun       Date:  2015-11-09       Impact factor: 3.441

6.  Artemisone effective against murine cerebral malaria.

Authors:  Judith H Waknine-Grinberg; Nicholas Hunt; Annael Bentura-Marciano; James A McQuillan; Ho-Wai Chan; Wing-Chi Chan; Yechezkel Barenholz; Richard K Haynes; Jacob Golenser
Journal:  Malar J       Date:  2010-08-09       Impact factor: 2.979

7.  Protection from experimental cerebral malaria with a single dose of radiation-attenuated, blood-stage Plasmodium berghei parasites.

Authors:  Noel J Gerald; Victoria Majam; Babita Mahajan; Yukiko Kozakai; Sanjai Kumar
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

8.  Indocyanine Green Liposomes for Diagnosis and Therapeutic Monitoring of Cerebral Malaria.

Authors:  Emma Portnoy; Natalia Vakruk; Ameer Bishara; Miriam Shmuel; Shlomo Magdassi; Jacob Golenser; Sara Eyal
Journal:  Theranostics       Date:  2016-01-01       Impact factor: 11.556

9.  Mannose inhibits Plasmodium parasite growth and cerebral malaria development via regulation of host immune responses.

Authors:  Li Lv; Zihao Xu; Meichen Zhao; Jian Gao; Rumeng Jiang; Qian Wang; Xiaoyu Shi
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

10.  Schistosoma mansoni infection reduces the incidence of murine cerebral malaria.

Authors:  Judith H Waknine-Grinberg; Daniel Gold; Ariel Ohayon; Eliezer Flescher; Alina Heyfets; Michael J Doenhoff; Gabriele Schramm; Helmut Haas; Jacob Golenser
Journal:  Malar J       Date:  2010-01-05       Impact factor: 2.979

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.